4.8 Article

The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Biochemistry & Molecular Biology

Inhibition of p53 protein aggregation as a cancer treatment strategy

Kalvin Kwan et al.

Summary: The p53 protein plays a crucial role in preventing genome mutations, but it is often mutated in cancer, leading to malfunction in the p53 pathway. Mutant p53 protein not only loses its activity, but also tends to unfold and aggregate, forming amyloid aggregates. This review discusses recent advancements in developing small-molecule stabilizers of mutant p53 protein and inhibitors of p53 aggregation.

CURRENT OPINION IN CHEMICAL BIOLOGY (2023)

Review Pharmacology & Pharmacy

ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance

Jingyi Fan et al.

Summary: Multidrug resistance (MDR) is when cancer cells become resistant to a wide range of unrelated drugs. This hinders cancer treatment and is a major cause of chemotherapy failure. ABC transporters are frequently overexpressed in MDR cancer cells, promoting drug efflux and reducing drug accumulation. Recent evidence suggests that ABC transporters also regulate the tumor immune microenvironment (TIME) by transporting cytokines, influencing anti-tumor immunity and drug sensitivity. Inhibition of ABC transporter expression or function can enhance the efficacy of immune checkpoint inhibitors by promoting an anticancer immune microenvironment. This review provides an update on current research progress in this field.

DRUG RESISTANCE UPDATES (2023)

Article Endocrinology & Metabolism

Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score

Laura Boucai et al.

Summary: Two subtypes of BRAF-mutant PTCs (BRAF-TDShi and BRAF-TDSlo) show significant differences in demographic distribution, tumor size, lymph node involvement, and distant metastases, indicating distinct clinical characteristics and prognosis.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Review Oncology

TGFβ: Signaling Blockade for Cancer Immunotherapy

Szu-Ying Chen et al.

Summary: This article discusses the biological effects of transforming growth factor beta (TGFβ) on different cells, with a focus on its impact on the adaptive immune system to improve immunotherapy outcomes. The authors also present recent advances in the development of drugs targeting the TGFβ signaling pathway in a tumor-specific or cell type-specific manner to optimize the therapeutic window between response rates and adverse effects.

ANNUAL REVIEW OF CANCER BIOLOGY (2022)

Article Medicine, General & Internal

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

Changfa Xia et al.

Summary: The study compared the latest cancer profiles, trends, and determinants between China and the USA in 2022. China has a higher incidence of lung cancer, while the USA has more cases of breast cancer. Recent years have seen a significant decrease in lung and colorectal cancer rates in the USA, while liver cancer rates have slightly increased. In China, rates for stomach, liver, and esophageal cancer have decreased gradually, but colorectal cancer rates have increased for the whole population.

CHINESE MEDICAL JOURNAL (2022)

Review Oncology

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

Xuhui Tong et al.

Summary: This article discusses the molecular processes and effects of necroptosis, pyroptosis, ferroptosis, and cuproptosis on tumor cell proliferation and cancer metastasis, as well as the complex effects of these novel types of tumor cell death on the tumor microenvironment and regulated death of other cells in the microenvironment.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Genetics & Heredity

A comprehensive prognostic and immune infiltration analysis of EXOC3L1 in pan-cancer

Zhan-Fei Zhang

Summary: This study found that EXOC3L1 is differentially expressed in various tumors and is associated with clinical outcomes and the immune microenvironment. It may affect the occurrence and development of tumors through the NOTCH signaling pathway, PI3K-AKT signaling pathway, and immune-related pathways. Therefore, EXOC3L1 may serve as a potential prognostic biomarker and a promising target for cancer immunotherapy in a variety of cancers.

FRONTIERS IN GENETICS (2022)

Article Oncology

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

Jessica K. Lee et al.

Summary: Recent clinical development of KRAS inhibitors has increased interest in the genomic landscape of KRAS-altered cancers. Comprehensive genomic profiling revealed the prevalence of KRAS alterations and identified co-alterations and biomarkers associated with KRAS mutations.

NPJ PRECISION ONCOLOGY (2022)

Review Endocrinology & Metabolism

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects

Ivana Puliafito et al.

Summary: Thyroid cancer is the most common endocrine malignancy, and its subtypes have been studied for novel therapeutic options. These treatments often come with side effects that require optimal management.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Immunology

Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme

Long Mu et al.

Summary: ASB3 is aberrantly expressed in various tumors, particularly in GBM, and is significantly correlated with patient prognosis, TMB, MSI, and immune cell infiltration. In GBM, ASB3 expression is negatively associated with Tregs, cancer-associated fibroblasts, and oncogenetic signaling pathways. Overexpression of ASB3 reduces the proportion of Tregs in TILs.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment

Zuzana Saidak et al.

Summary: This study analyzed the expression of 6 key coagulation/fibrinolysis genes in 32 different types of tumors and identified specific expression patterns. The results showed that the expression of these genes is associated with tumor type and characteristics of the tumor microenvironment, potentially explaining the differences in venous thromboembolism risk among different tumor types.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Genetics & Heredity

Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients

Zheng Zhao et al.

Summary: The Chinese Glioma Genome Atlas (CGGA) is a user-friendly data portal for the storage and interactive exploration of cross-omics data related to gliomas. It provides researchers with rapid and convenient access to high-quality functional genomic data resources for biological studies and clinical applications.

GENOMICS PROTEOMICS & BIOINFORMATICS (2021)

Article Multidisciplinary Sciences

Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48

Sally A. Clayton et al.

Summary: Dysregulated mitochondrial function is a key feature of immune-mediated inflammatory diseases. The CcO subunit NDUFA4 can be replaced by C15ORF48 in response to inflammatory signals, affecting disease severity. Moreover, the expression of C15orf48 is associated with rheumatoid arthritis and severe COVID-19, indicating potential implications for disease progression.

SCIENCE ADVANCES (2021)

Article Genetics & Heredity

A genome-wide atlas of co-essential modules assigns function to uncharacterized genes

Michael Wainberg et al.

Summary: A new statistical method has been developed to robustly identify gene co-essentiality and yield a genome-wide set of functional modules, predicting the functions of 108 uncharacterized genes effectively.

NATURE GENETICS (2021)

Article Multidisciplinary Sciences

Coding and non-coding roles of MOCCI (C15ORF48) coordinate to regulate host inflammation and immunity

Cheryl Q. E. Lee et al.

Summary: The study identifies a mito-SEP named MOCCI, which can replace NDUFA4 during inflammation to reduce mitochondrial membrane potential and ROS production, providing cell protection and suppressing immune responses. Additionally, the MOCCI transcript generates miR-147b, which enhances antiviral immune responses.

NATURE COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Inflammation and tumor progression: signaling pathways and targeted intervention

Huakan Zhao et al.

Summary: Inflammation plays a crucial role in cancer development and therapy, either promoting or inhibiting tumor progression and therapeutic outcomes. Various signaling pathways and factors have been identified as pivotal regulators of inflammation initiation and resolution.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Pharmacology & Pharmacy

Immunotherapy for Malignant Glioma: Current Status and Future Directions

Hongxiang Wang et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Article Medicine, Research & Experimental

Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme

Corey Smith et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Oncology

The cancer-natural killer cell immunity cycle

Nicholas D. Huntington et al.

NATURE REVIEWS CANCER (2020)

Article Mathematical & Computational Biology

FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations

Nan Zhou et al.

DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2020)

Review Immunology

Reprogramming of mitochondrial metabolism by innate immunity

Johan Garaude

CURRENT OPINION IN IMMUNOLOGY (2019)

Correction Immunology

The Immune Landscape of Cancer (vol 48, pg 812, 2018)

Vesteinn Thorsson et al.

IMMUNITY (2019)

Review Multidisciplinary Sciences

A view on drug resistance in cancer

Neil Vasan et al.

NATURE (2019)

Article Oncology

TIP: A Web Server for Resolving Tumor Immunophenotype Profiling

Liwen Xu et al.

CANCER RESEARCH (2018)

Article Oncology

Landscape of Microsatellite Instability Across 39 Cancer Types

Russell Bonneville et al.

JCO PRECISION ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function

Brendan J. Floyd et al.

MOLECULAR CELL (2016)

Article Oncology

A phase 2 study of tremelimumab in patients with advanced uveal melanoma

Anthony M. Joshua et al.

MELANOMA RESEARCH (2015)

Article Oncology

Radiation and Inflammation

Doerthe Schaue et al.

SEMINARS IN RADIATION ONCOLOGY (2015)

Review Oncology

The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer

Graeme J. K. Guthrie et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)

Article Cell Biology

Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

Stefani Spranger et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Multidisciplinary Sciences

Genome-Wide Screening of Genes Regulated by DNA Methylation in Colon Cancer Development

Sandor Spisak et al.

PLOS ONE (2012)

Article Multidisciplinary Sciences

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim et al.

NATURE (2010)

Article Oncology

A novel gene, NMES1, downregulated in human esophageal squamous cell carcinoma

J Zhou et al.

INTERNATIONAL JOURNAL OF CANCER (2002)